Czech National Bank Increases Stake in Tyler Technologies by Lilu Anderson 22.06.2024 Czech National Bank boosts stake in Tyler Technologies (NYSE:TYL) by 0.6% to $3.15M in Q1. Major investors and analysts show ...
ASE Technology Hits 12-Month High at $11.78 Amid Major Investments by Lilu Anderson 20.06.2024 ASE Technology (NYSE:ASX) hits a 12-month high at $11.78, earning a "buy" rating from StockNews.com; strong performance and investor interest ...
Experts Predict Dogecoin ETF as Meme Coins Gain Traction by John Darbie 16.06.2024 Dogecoin could potentially secure an ETF by the market cycle's end, BitMEX's Hayes and Pal agree. DOGE trades at $0.13. ...
Horizon Technology Finance Announces Monthly Dividend of $0.11 by Mark Eisenberg 15.06.2024 Horizon Technology Finance posts $1.32 annual dividend, yielding 11.01%. Ex-dividend date: June 17. EPS forecast: $1.48 for the year. NYSE:CX.
Debt Markets Jittery as Morgan Stanley Warns Fed Hikes by Terry Bingman 25.04.2024 Morgan Stanley suggests credit trouble may arise if the Fed hikes rates, as spreads widen for US investment-grade debt while ...
Is Bank of America Stock a Buy on This Dip? by Mark Eisenberg 25.04.2024 Bank of America faces challenges with interest rates, but business and personal customers continue to trust the bank. Motley Fool ...
Are You Ready for Retirement? Insider Tips by Mark Eisenberg 24.04.2024 By 2030, all Baby Boomers will be older than 65. Waiting to file for retirement can increase benefit payments by ...
Apartment Investment and Management Co: Financial Report Analysis by Mark Eisenberg 28.03.2024 Explore the financial stability of Aimco's stock amid market fluctuations. Delve into key metrics and potential for growth. Dive deeper ...
Moleculin Biotech Stock Coverage and Analysis at StockNews by Mark Eisenberg 28.03.2024 Moleculin Biotech's stock has been given a "sell" rating by a firm, with a 1-year low of $4.34 and a ...
Moleculin Biotech Stock Receives “Sell” Rating – Analysts by Mark Eisenberg 28.03.2024 Atticus Wealth Management LLC buys stake in Moleculin Biotech as the firm sets a “sell” rating on the stock; MBRX ...